Northwest Biotherapeutics Inc (NWBO) stock
NWBOOTCPharmaceutical PreparationsFiscal year ends December 31
$0.16−0.00 (-0.88%)
Close on Oct 19, 2026Market cap $254.79MP/E –Yield –
Northwest Biotherapeutics profit margin
Profit margin (net margin) is net income as a percentage of revenue.
Northwest Biotherapeutics's profit margin for the twelve months ending Jun 30, 2026 was -1736.4%. For fiscal 2025 it was -4365.9%, against -6062.1% the year before. The highest annual figure on record is 17823.5% in fiscal 2021.
Annual profit margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -4365.9% | +1696.2 |
| FY2024 | Dec 31, 2024 | -6062.1% | −2822.0 |
| FY2023 | Dec 31, 2023 | -3240.1% | +3000.6 |
| FY2022 | Dec 31, 2022 | -6240.8% | −24064.2 |
| FY2021 | Dec 31, 2021 | 17823.5% | +58863.1 |
| FY2020 | Dec 31, 2020 | -41039.6% | −40176.0 |
| FY2019 | Dec 31, 2019 | -863.6% | +7824.3 |
| FY2018 | Dec 31, 2018 | -8687.9% | +13080.9 |
| FY2017 | Dec 31, 2017 | -21768.8% | −8893.3 |
| FY2016 | Dec 31, 2016 | -12875.4% | −6277.3 |
| FY2015 | Dec 31, 2015 | -6598.1% | +2730.2 |
| FY2014 | Dec 31, 2014 | -9328.3% | −1196.2 |
| FY2013 | Dec 31, 2013 | -8132.1% | +588.1 |
| FY2012 | Dec 31, 2012 | -8720.2% | +319579.8 |
| FY2011 | Dec 31, 2011 | -328300.0% | −54620.0 |
| FY2010 | Dec 31, 2010 | -273680.0% | – |
Quarterly profit margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -1142.6% | +10596.3 |
| Q1 FY2026 | Mar 31, 2026 | -621.3% | +4536.9 |
| Q4 FY2025 | Dec 31, 2025 | 206.5% | +12424.3 |
| Q3 FY2025 | Sep 30, 2025 | -13414.5% | −7987.6 |
| Q2 FY2025 | Jun 30, 2025 | -11738.9% | −8235.2 |
| Q1 FY2025 | Mar 31, 2025 | -5158.1% | +1289.8 |
| Q4 FY2024 | Dec 31, 2024 | -12217.7% | −9076.9 |
| Q3 FY2024 | Sep 30, 2024 | -5426.9% | +366.7 |
| Q2 FY2024 | Jun 30, 2024 | -3503.7% | +3684.3 |
| Q1 FY2024 | Mar 31, 2024 | -6447.9% | −5237.4 |
| Q4 FY2023 | Dec 31, 2023 | -3140.9% | +1599.1 |
| Q3 FY2023 | Sep 30, 2023 | -5793.6% | +10154.0 |
| Q2 FY2023 | Jun 30, 2023 | -7188.1% | −968.4 |
| Q1 FY2023 | Mar 31, 2023 | -1210.5% | +2316.6 |
| Q4 FY2022 | Dec 31, 2022 | -4740.0% | −17745.5 |
| Q3 FY2022 | Sep 30, 2022 | -15947.6% | +39777.9 |
| Q2 FY2022 | Jun 30, 2022 | -6219.7% | +83639.6 |
| Q1 FY2022 | Mar 31, 2022 | -3527.0% | +2899073.0 |
| Q3 FY2021 | Sep 30, 2021 | 13005.4% | +12544.7 |
| Q4 FY2020 | Dec 31, 2020 | -55725.4% | −56455.1 |
| Q3 FY2020 | Sep 30, 2020 | -89859.3% | −88784.9 |
| Q2 FY2020 | Jun 30, 2020 | -2902600.0% | −2902637.7 |
| Q1 FY2020 | Mar 31, 2020 | 460.7% | +6639.5 |
| Q4 FY2019 | Dec 31, 2019 | 729.7% | −2046.9 |
| Q3 FY2019 | Sep 30, 2019 | -1074.4% | +6543.3 |
| Q2 FY2019 | Jun 30, 2019 | 37.7% | +16359.7 |
| Q1 FY2019 | Mar 31, 2019 | -6178.8% | +78193.1 |
| Q3 FY2018 | Sep 30, 2018 | 2776.6% | +46024.5 |
| Q2 FY2018 | Jun 30, 2018 | -7617.6% | +10764.1 |
| Q1 FY2018 | Mar 31, 2018 | -16322.0% | −7293.3 |
| Q4 FY2017 | Dec 31, 2017 | -84371.9% | −81784.6 |
| Q4 FY2016 | Dec 31, 2016 | -43247.9% | −40457.9 |
| Q3 FY2016 | Sep 30, 2016 | -18381.8% | – |
| Q2 FY2016 | Jun 30, 2016 | -9028.7% | – |
| Q1 FY2016 | Mar 31, 2016 | -2587.3% | – |
| Q4 FY2015 | Dec 31, 2015 | -2790.0% | – |
See a number that looks wrong?